Polymorphonuclear-MDSCs Facilitate Tumor Regrowth After Radiation by Suppressing CD8+ T Cells
- 22 November 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 109 (5), 1533-1546
- https://doi.org/10.1016/j.ijrobp.2020.11.038
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China
This publication has 48 references indexed in Scilit:
- Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic TumorsFrontiers in Immunology, 2019
- The Integration of Radiotherapy with Immunotherapy for the Treatment of Non–Small Cell Lung CancerClinical Cancer Research, 2018
- Myeloid‐derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapyInternational Journal of Cancer, 2018
- Host STING-dependent MDSC mobilization drives extrinsic radiation resistanceNature Communications, 2017
- Radiotherapy in the age of cancer immunology: Current concepts and future developmentsCritical Reviews in Oncology/Hematology, 2017
- Mathematical Modeling of Cancer Immunotherapy and Its Synergy with RadiotherapyCancer Research, 2016
- CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate CancerCancer Research, 2013
- Irradiation Promotes an M2 Macrophage Phenotype in Tumor HypoxiaFrontiers in Oncology, 2012
- Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic CellsCancer Cell, 2008
- Whole Body Irradiation—Radiobiology or Medicine?The British Journal of Radiology, 1953